$226.67
Value $127B
LOW and NHTC stock compared: price, dividend, valuation and results, from SEC filings.
$226.67
Value $127B
$0.74
Value $6.3M
Lowe's Companies (LOW) has a market value of $127B and Natural Health Trends (NHTC) $6.3M. Over the last year, with dividends, LOW moved +1.5% and NHTC -76.7%. Dividend yield: LOW 2.16%, NHTC none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
LOW$127B
NHTC$6.3M
LOW is 20,002 times NHTC
Revenue, 12 months
LOW$90.4B
NHTC$34M
LOW is 2,651 times NHTC
Net income, 12 months
LOW$6.6B
NHTC-$1.4M
Operating margin
LOW11.4%
NHTC-5.9%
17.3 points apart
ROIC
LOW27.6%
NHTC-8.3%
35.9 points apart
P/E
LOW19.2
NHTC–
Dividend yield
LOW2.2%
NHTC0.0%
2.2 points apart
5-year return
LOW+6.4%
NHTC-82.0%
88.4 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
LOW+6.4%
NHTC-82.0%
| Period | LOWWith dividends | NHTCWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +1.5%Price -0.7% | -76.7%Price -79.4% |
| 3 years since November 16, 2023 | +18.9%+5.9% a yearPrice +11.9% | -80.1%-41.6% a yearPrice -86.2% |
| 5 years since November 15, 2021 | +6.4%+1.3% a yearPrice -3.6% | -82.0%-29.0% a yearPrice -90.6% |
| 10 years since November 16, 2016 | +308.0%+15.1% a yearPrice +237.7% | -90.3%-20.8% a yearPrice -97.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
LOWLowe's CompaniesNHTCNatural Health Trends
| Price | $226.67 | $0.74 |
|---|---|---|
| Market value | $127B | $6.3M |
| Enterprise value (EV) | $161B | – |
| P/E | 19.2 | – |
| P/E, 5-year median | 21.2 | – |
| P/B | – | 0.4 |
| EV/EBIT | 15.7 | – |
| Free cash flow yield | 5.5% | – |
| Revenue, 12 months | $90.4B | $34M |
|---|---|---|
| Net income, 12 months | $6.6B | -$1.4M |
| Free cash flow, 12 months | $7.0B | -$4.7M |
| Earnings per share, 12 months | $11.83 | -$0.15 |
| Revenue growth, year on year | 3.1% | -7.4% |
| Revenue growth a year, past | -0.8%over 5 years | -8.5%over 5 years |
| EPS growth a year, past | +8.9%over 5 years | – |
| Gross margin | 33.1% | 74.3% |
|---|---|---|
| Operating margin | 11.4% | -5.9% |
| Net margin | 7.3% | -4.2% |
| ROIC | 27.6% | -8.3% |
| ROE | – | -7.4% |
| Cash | $3.4B | $18M |
|---|---|---|
| Total debt | $42.0B | $2.6M |
| Net debt / EBITDA | 2.7 | – |
| Interest cover | – | – |
| Dividend yield | 2.2% | – |
|---|---|---|
| Dividend per share, 12 months | $4.90 | $0.60 |
| Dividend growth a year, past | +15.6%over 5 years | +0.0%over 5 years |
| Buyback yield | 0.2% | – |
| Shareholder yield | 2.3% | 81.1% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Lowe's Companies ($127B) is about 20,002.3 times Natural Health Trends ($6.3M), at today's prices.
Since November 16, 2016, LOW's price moved +237.7% and NHTC's -97.0%. With dividends: LOW +308.0% (+15.1% a year), NHTC -90.3% (-20.8% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.16% for Lowe's Companies and none for Natural Health Trends. Over the last twelve months they paid $4.90 and $0.60 per share.
Over the last twelve months, the net margin was 7.3% for Lowe's Companies and -4.2% for Natural Health Trends, and the operating margin 11.4% and -5.9%. Revenue was $90.4B and $34M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.